
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A45000038A64B005063.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="mtonc" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10963938/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10963938/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Molecular Therapy Oncology" /><meta name="citation_title" content="MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer" /><meta name="citation_author" content="Takashi Oda" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan" /><meta name="citation_author" content="Koichiro Tsutsumi" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Taisuke Obata" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan" /><meta name="citation_author" content="Eijiro Ueta" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Tatsuya Kikuchi" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan" /><meta name="citation_author" content="Soichiro Ako" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Yuki Fujii" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Tatsuhiro Yamazaki" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Daisuke Uchida" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Kazuyuki Matsumoto" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Shigeru Horiguchi" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Hironari Kato" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Hiroyuki Okada" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Ryota Chijimatsu" /><meta name="citation_author_institution" content="Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan" /><meta name="citation_author" content="Motoyuki Otsuka" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan" /><meta name="citation_author_institution" content="Department of Gastroenterology, Okayama University Hospital, Okayama, Japan" /><meta name="citation_publication_date" content="2024/03/03" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="32" /><meta name="citation_doi" content="10.1016/j.omton.2024.200765" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10963938/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10963938/" /><meta name="citation_pmid" content="38596294" /><meta name="DC.Title" content="MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="American Society of Gene &#x0026; Cell Therapy" /><meta name="DC.Contributor" content="Takashi Oda" /><meta name="DC.Contributor" content="Koichiro Tsutsumi" /><meta name="DC.Contributor" content="Taisuke Obata" /><meta name="DC.Contributor" content="Eijiro Ueta" /><meta name="DC.Contributor" content="Tatsuya Kikuchi" /><meta name="DC.Contributor" content="Soichiro Ako" /><meta name="DC.Contributor" content="Yuki Fujii" /><meta name="DC.Contributor" content="Tatsuhiro Yamazaki" /><meta name="DC.Contributor" content="Daisuke Uchida" /><meta name="DC.Contributor" content="Kazuyuki Matsumoto" /><meta name="DC.Contributor" content="Shigeru Horiguchi" /><meta name="DC.Contributor" content="Hironari Kato" /><meta name="DC.Contributor" content="Hiroyuki Okada" /><meta name="DC.Contributor" content="Ryota Chijimatsu" /><meta name="DC.Contributor" content="Motoyuki Otsuka" /><meta name="DC.Date" content="2024 Mar 21" /><meta name="DC.Identifier" content="10.1016/j.omton.2024.200765" /><meta name="DC.Language" content="en" /><meta property="og:title" content="MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer" /><meta property="og:type" content="article" /><meta property="og:description" content="Gallbladder cancer incidence has been increasing globally, and&#x000a0;it remains challenging to expect long prognosis with the current systemic chemotherapy. We identified a novel nucleic acid-mediated therapeutic target against gallbladder cancer by ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10963938/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10963938/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/4545/">Mol Ther Oncol</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/455933/">v.32(1); 2024 Mar 21</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10963938
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10963938/pdf/main.pdf" class="int-view">PDF (3.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10963938/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10963938/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10963938" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10963938%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="g0SpYhFiyGmk5LZtRsTdZtDF3DRp2mK4jzikbaR7k9NwBpp4DyQKk8WEu3XXdM1G">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10963938%2F&amp;text=MicroRNA-34a-5p%3A%20A%20pivotal%20therapeutic%20target%20in%20gallbladder%20cancer" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10963938%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10963938/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10963938/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38596294/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10963938/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38596294/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10963938/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10963938/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/4545/">Mol Ther Oncol</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/455933/">v.32(1); 2024 Mar 21</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10963938
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><a href="//doi.org/10.1016%2Fj.omton.2024.200765" title="Link to Publisher's site" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"><img src="/corehtml/pmc/pmcgifs/logo-mtonc.png" alt="Logo of mtonc"><!-- --></img></a></div>
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Mol Ther Oncol.</span> 2024 Mar 21; 32(1): 200765. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2024 Feb 8. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.omton.2024.200765" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.omton.2024.200765</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10963938</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38596294">38596294</a></div></div></div><h1 class="content-title">MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Oda%20T%5BAuthor%5D" id="au1" class="affpopup" co-rid="_co_idm140714691548368" co-class="co-affbox">Takashi Oda</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tsutsumi%20K%5BAuthor%5D" id="au2" class="affpopup" co-rid="_co_idm140714691547632" co-class="co-affbox">Koichiro Tsutsumi</a>,<sup>2,</sup><sup>&#x02217;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Obata%20T%5BAuthor%5D" id="au3" class="affpopup" co-rid="_co_idm140714694925952" co-class="co-affbox">Taisuke Obata</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ueta%20E%5BAuthor%5D" id="au4" class="affpopup" co-rid="_co_idm140714695236656" co-class="co-affbox">Eijiro Ueta</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kikuchi%20T%5BAuthor%5D" id="au5" class="affpopup" co-rid="_co_idm140714695234544" co-class="co-affbox">Tatsuya Kikuchi</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ako%20S%5BAuthor%5D" id="au6" class="affpopup" co-rid="_co_idm140714695232320" co-class="co-affbox">Soichiro Ako</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fujii%20Y%5BAuthor%5D" id="au7" class="affpopup" co-rid="_co_idm140714695230096" co-class="co-affbox">Yuki Fujii</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamazaki%20T%5BAuthor%5D" id="au8" class="affpopup" co-rid="_co_idm140714695227872" co-class="co-affbox">Tatsuhiro Yamazaki</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Uchida%20D%5BAuthor%5D" id="au9" class="affpopup" co-rid="_co_idm140714695225648" co-class="co-affbox">Daisuke Uchida</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Matsumoto%20K%5BAuthor%5D" id="au10" class="affpopup" co-rid="_co_idm140714693179104" co-class="co-affbox">Kazuyuki Matsumoto</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Horiguchi%20S%5BAuthor%5D" id="au11" class="affpopup" co-rid="_co_idm140714693176880" co-class="co-affbox">Shigeru Horiguchi</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kato%20H%5BAuthor%5D" id="au12" class="affpopup" co-rid="_co_idm140714693174656" co-class="co-affbox">Hironari Kato</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Okada%20H%5BAuthor%5D" id="au13" class="affpopup" co-rid="_co_idm140714693172432" co-class="co-affbox">Hiroyuki Okada</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chijimatsu%20R%5BAuthor%5D" id="au14" class="affpopup" co-rid="_co_idm140714693169472" co-class="co-affbox">Ryota Chijimatsu</a>,<sup>3</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Otsuka%20M%5BAuthor%5D" id="au15" class="affpopup" co-rid="_co_idm140714693167248" co-class="co-affbox">Motoyuki Otsuka</a><sup>1,</sup><sup>2,</sup><sup>&#x02217;&#x02217;</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140714691548368"><h3 class="no_margin">Takashi Oda</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Oda%20T%5BAuthor%5D">Takashi Oda</a></div></div><div id="_co_idm140714691547632"><h3 class="no_margin">Koichiro Tsutsumi</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tsutsumi%20K%5BAuthor%5D">Koichiro Tsutsumi</a></div></div><div id="_co_idm140714694925952"><h3 class="no_margin">Taisuke Obata</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Obata%20T%5BAuthor%5D">Taisuke Obata</a></div></div><div id="_co_idm140714695236656"><h3 class="no_margin">Eijiro Ueta</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ueta%20E%5BAuthor%5D">Eijiro Ueta</a></div></div><div id="_co_idm140714695234544"><h3 class="no_margin">Tatsuya Kikuchi</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kikuchi%20T%5BAuthor%5D">Tatsuya Kikuchi</a></div></div><div id="_co_idm140714695232320"><h3 class="no_margin">Soichiro Ako</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ako%20S%5BAuthor%5D">Soichiro Ako</a></div></div><div id="_co_idm140714695230096"><h3 class="no_margin">Yuki Fujii</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fujii%20Y%5BAuthor%5D">Yuki Fujii</a></div></div><div id="_co_idm140714695227872"><h3 class="no_margin">Tatsuhiro Yamazaki</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamazaki%20T%5BAuthor%5D">Tatsuhiro Yamazaki</a></div></div><div id="_co_idm140714695225648"><h3 class="no_margin">Daisuke Uchida</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Uchida%20D%5BAuthor%5D">Daisuke Uchida</a></div></div><div id="_co_idm140714693179104"><h3 class="no_margin">Kazuyuki Matsumoto</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Matsumoto%20K%5BAuthor%5D">Kazuyuki Matsumoto</a></div></div><div id="_co_idm140714693176880"><h3 class="no_margin">Shigeru Horiguchi</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Horiguchi%20S%5BAuthor%5D">Shigeru Horiguchi</a></div></div><div id="_co_idm140714693174656"><h3 class="no_margin">Hironari Kato</h3><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kato%20H%5BAuthor%5D">Hironari Kato</a></div></div><div id="_co_idm140714693172432"><h3 class="no_margin">Hiroyuki Okada</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan</p><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Okada%20H%5BAuthor%5D">Hiroyuki Okada</a></div></div><div id="_co_idm140714693169472"><h3 class="no_margin">Ryota Chijimatsu</h3><p><sup>3</sup>Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chijimatsu%20R%5BAuthor%5D">Ryota Chijimatsu</a></div></div><div id="_co_idm140714693167248"><h3 class="no_margin">Motoyuki Otsuka</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan</p><p><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Otsuka%20M%5BAuthor%5D">Motoyuki Otsuka</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140714690371424_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140714690371424_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140714690371424_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140714690371424_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>1</sup>Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan</div><div class="fm-affl" id="aff2"><sup>2</sup>Department of Gastroenterology, Okayama University Hospital, Okayama, Japan</div><div class="fm-affl" id="aff3"><sup>3</sup>Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan</div><div><span class="contrib-email" id="au2">Koichiro Tsutsumi: <a href="mailto:dev@null" data-email="pj.ca.u-amayako@imustust" class="oemail">pj.ca.u-amayako@imustust</a>; </span> <span class="contrib-email" id="au15">Motoyuki Otsuka: <a href="mailto:dev@null" data-email="pj.ca.u-amayako@otomakusto" class="oemail">pj.ca.u-amayako@otomakusto</a></span> </div><div id="cor1"><sup>&#x02217;</sup>Corresponding author: Koichiro Tsutsumi, Department of Gastroenterology, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan. <a href="mailto:dev@null" data-email="pj.ca.u-amayako@imustust" class="oemail">pj.ca.u-amayako@imustust</a></div><div id="cor2"><sup>&#x02217;&#x02217;</sup>Corresponding author: Motoyuki Otsuka, Department of Gastroenterology, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan. <a href="mailto:dev@null" data-email="pj.ca.u-amayako@otomakusto" class="oemail">pj.ca.u-amayako@otomakusto</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm140714690371424_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Jul 22; Revised 2023 Nov 4; Accepted 2024 Jan 18.</div></div><div class="permissions half_rhythm hide" id="idm140714690371424_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2024 The Author(s)</div><div class="license half_rhythm">This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="2" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Document S1. Figures&#x000a0;S1&#x02012;S6</div><div><a href="/pmc/articles/PMC10963938/bin/mmc1.pdf" data-ga-action="click_feat_suppl">mmc1.pdf</a><span style="color:gray"> (706K)</span></div><div class="small guid">GUID: 3C82E231-D7A1-496F-B318-B8572B403578</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Document S2. Article plus supplemental information</div><div><a href="/pmc/articles/PMC10963938/bin/mmc2.pdf" data-ga-action="click_feat_suppl">mmc2.pdf</a><span style="color:gray"> (4.2M)</span></div><div class="small guid">GUID: 13612BBF-6811-4B83-87DD-014360CBDE62</div></div></dd></dl><dl data-length="129" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">All of the data, materials, and protocols used in this study are available from the corresponding author upon reasonable request.</p></dd></dl></div><div id="abs0010" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0010title">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Gallbladder cancer incidence has been increasing globally, and&#x000a0;it remains challenging to expect long prognosis with the current systemic chemotherapy. We identified a novel nucleic acid-mediated therapeutic target against gallbladder cancer by using innovative organoid-based gallbladder cancer models generated from <em>Kras</em><sup>LSL-G12D/+</sup>; <em>Trp53</em><sup>f/f</sup> mice. Using comprehensive microRNA expression analyses and a bioinformatics approach, we identified significant microRNA-34a-5p downregulation in both murine gallbladder cancer organoids and resected human gallbladder cancer specimens. In three different human gallbladder cancer cell lines, forced microRNA-34a-5p expression inhibited cell proliferation and induced cell-cycle arrest at the G1 phase by suppressing direct target (<em>CDK6</em>) expression. Furthermore, comprehensive RNA sequencing revealed the significant enrichment of gene sets related to the cell-cycle regulators after microRNA-34a-5p expression in gallbladder cancer cells. In a murine xenograft model, locally injected microRNA-34a-5p mimics significantly inhibited gallbladder cancer progression and downregulated <em>CDK6</em> expression. These results provide a rationale for promising therapeutics against gallbladder cancer by microRNA-34a-5p injection, as well as a strategy to explore therapeutic targets against cancers using organoid-based models, especially for those lacking useful genetically engineered murine models, such as gallbladder cancer.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">MT: Regular Issue, carcinogenesis, organoid, gallbladder cancer, microRNA, miR-34a-5p, cell cycle, CDK6, xenograft, biliary tract, therapy</span></div></div><div id="abs0015a" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0015atitle">Graphical abstract</h2><!--article-meta--><div><!--fig ft0--><!--fig @position="anchor" mode=article f4--><!--fig mode="anchored" f5--><div class="fig graphic_only iconblock anchored whole_rhythm" id="undfig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140714738070448"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fx1.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is fx1.jpg" src="/pmc/articles/PMC10963938/bin/fx1.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140714738070448"><a target="object" rel="noopener" href="/pmc/articles/PMC10963938/figure/undfig1/?report=objectonly">Open in a separate window</a></div></div></div></div><div id="abs0015" lang="en" class="tsec sec"><h2 class="headless nomenu"></h2><!--article-meta--><div><p class="p p-first-last">Oda and colleagues identified significant microRNA-34a-5p downregulation in both murine gallbladder cancer (GBC) organoids and resected human GBC specimens by using innovative organoid-based GBC models generated from <em>Kras</em><sup>LSL-G12D/+</sup>; <em>Trp53</em><sup>f/f</sup> mice. miR-34a-5p forced expression leads to efficient GBC progression suppression via cell-cycle inhibition by CDK6 downregulation.</p></div></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">Introduction</h2><p id="p0010" class="p p-first">The incidence of gallbladder cancer (GBC), a type of biliary tract cancer (BTC), has increased worldwide. However, because it is difficult to diagnose at an early stage due to the lack of clinical manifestations,<a href="#bib1" rid="bib1" class=" bibr popnode"><sup>1</sup></a> radical surgery is rarely performed. Moreover, although systemic chemotherapy has progressed, it is not sufficient to improve prognosis, and the 5-year survival rate remains &#x0003c;20%.<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a> Recently, whole-exome sequencing has revealed a landscape of genomic alterations in BTC, and various altered genes, such as <em>TP53</em>, <em>KRAS</em>, <em>SMAD4</em>, <em>ARID1A</em>, and <em>PIK3CA</em>, have been identified in GBC.<a href="#bib3" rid="bib3" class=" bibr popnode"><sup>3</sup></a><sup>,</sup><a href="#bib4" rid="bib4" class=" bibr popnode"><sup>4</sup></a> In some cases with <em>NTRK</em> gene fusion-positive tumors, mismatch repair-deficient tumors, or microsatellite instability-high tumors, <em>NTRK</em> inhibitors or immune checkpoint inhibitors are expected to exhibit a high treatment effect<a href="#bib5" rid="bib5" class=" bibr popnode"><sup>5</sup></a><sup>,</sup><a href="#bib6" rid="bib6" class=" bibr popnode"><sup>6</sup></a>; however, patients with such gene alterations account for &#x0003c;10% of patients with BTC. Therefore, there is an urgent need to develop novel treatments, including molecular-targeted therapies, for patients with GBC.</p><p id="p0015">To date, several studies have been conducted to investigate therapeutic targets using surgically resected specimens from patients with GBC.<a href="#bib4" rid="bib4" class=" bibr popnode"><sup>4</sup></a><sup>,</sup><a href="#bib7" rid="bib7" class=" bibr popnode"><sup>7</sup></a><sup>,</sup><a href="#bib8" rid="bib8" class=" bibr popnode"><sup>8</sup></a><sup>,</sup><a href="#bib9" rid="bib9" class=" bibr popnode"><sup>9</sup></a><sup>,</sup><a href="#bib10" rid="bib10" class=" bibr popnode"><sup>10</sup></a> However, only a few targets applicable to clinical use have been identified. This limited success can be attributed to numerous factors such as the analysis of bulk samples, a high degree of intra- and intertumor heterogeneity, and the use of unsuitable control samples. In addition, the lack of an ideal genetically engineered murine model that accurately reflects human primary GBC has hampered research. In recent years, three-dimensional (3D) cultured organoid-based research has become widespread in cancer biology.<a href="#bib11" rid="bib11" class=" bibr popnode"><sup>11</sup></a> This advanced <em>in&#x000a0;vitro</em> culture tool allows for long-term culture of normal stem cells under physiological conditions<a href="#bib12" rid="bib12" class=" bibr popnode"><sup>12</sup></a> and provides a high-throughput drug screening platform with improved reliability compared to conventional 2D culture systems.<a href="#bib13" rid="bib13" class=" bibr popnode"><sup>13</sup></a> Regarding the gallbladder (GB), an organoid-based carcinogenesis model using GB organoids derived from <em>Kras</em><sup>LSL-G12D/+</sup>; <em>Trp53</em><sup>f/f</sup> mice generated murine primary GBC organoids with mutant Kras and Trp53 loss.<a href="#bib14" rid="bib14" class=" bibr popnode"><sup>14</sup></a><sup>,</sup><a href="#bib15" rid="bib15" class=" bibr popnode"><sup>15</sup></a><sup>,</sup><a href="#bib16" rid="bib16" class=" bibr popnode"><sup>16</sup></a> These organoid-based carcinogenesis models present considerable potential as innovative tools for exploring GBC biology.</p><p id="p0020">With recent advances in nucleic acid-mediated therapies, novel therapeutic strategies targeting microRNAs (miRNAs) have been developed for various types of cancers,<a href="#bib17" rid="bib17" class=" bibr popnode"><sup>17</sup></a> including GBC.<a href="#bib18" rid="bib18" class=" bibr popnode"><sup>18</sup></a><sup>,</sup><a href="#bib19" rid="bib19" class=" bibr popnode"><sup>19</sup></a><sup>,</sup><a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a> However, the crucial miRNAs associated with GBC progression that could serve as high-priority therapeutic targets have not yet been identified.</p><p id="p0025" class="p p-last">In this study, we comprehensively examined the miRNA expression profiles of <em>Kras</em>-activated and <em>Trp53-</em>deleted tumorigenic GB organoids mimicking GBC and normal GB organoids mimicking the normal GB. We compared these profiles and identified pivotal therapeutic miRNA targets that regulate GBC progression. A direct gene target and comprehensive transcriptional changes after forced miRNA expression were determined, and the effects of local administration of the miRNA into mouse xenograft models were evaluated to develop a new therapeutic option against GBC.</p></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">Results</h2><div id="sec2.1" class="sec sec-first"><h3 id="sec2.1title">miR-34a-5p is downregulated in GBC</h3><p id="p0030" class="p p-first-last">To identify miRNAs that were differentially expressed between normal GB and GBC, we conducted a comprehensive miRNA expression analysis by comparing organoids mimicking normal GB and GBC. Although both types of organoids exhibited cyst formation (<a href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure&#x000a0;1</span></a>A), Cre-mediated induction of <em>Kras</em><sup>G12D</sup> and deletion of <em>Trp53</em> were observed only in GBC organoids (<a href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figures 1</span></a>B and <a href="#mmc1" rid="mmc1" class=" supplementary-material">S6</a>). Using qualified RNAs extracted from these organoids (<a href="#mmc1" rid="mmc1" class=" supplementary-material">Figure&#x000a0;S1</a>), the study revealed that the expression levels of 144 kinds of miRNAs and 91 miRNAs were higher (log<sub>2</sub>FC [fold change]&#x000a0;&#x0003e;&#x000a0;1) and lower (log<sub>2</sub>FC&#x000a0;&#x0003c;&#x000a0;&#x02212;1), respectively, in GBC organoids than in normal GB organoids in the miRNA microarray analyses (<a href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figures&#x000a0;1</span></a>C and 1D). When focusing on miRNAs with a signal intensity &#x0003e;25, the expression levels of 18 miRNAs were higher (log<sub>2</sub>FC&#x000a0;&#x0003e;&#x000a0;1) and those of 19 miRNAs were lower (log<sub>2</sub>FC&#x000a0;&#x0003c;&#x000a0;&#x02212;1) in GBC organoids than in normal GB organoids. Although miR-21a-5p, a well-known oncogenic miRNA, was upregulated, four types of miRNAs&#x02014;miR-34a-5p, miR-181a-5p, miR-378a-3p, and miR-205-5p, which have been implicated as tumor suppressors in various cancers<a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a><sup>,</sup><a href="#bib22" rid="bib22" class=" bibr popnode"><sup>22</sup></a><sup>,</sup><a href="#bib23" rid="bib23" class=" bibr popnode"><sup>23</sup></a><sup>,</sup><a href="#bib24" rid="bib24" class=" bibr popnode"><sup>24</sup></a><sup>,</sup><a href="#bib25" rid="bib25" class=" bibr popnode"><sup>25</sup></a>&#x02014;exhibited decreased expression levels in GBC organoids (<a href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure&#x000a0;1</span></a>E). Through validation of the expression levels of these four miRNAs by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), the downregulation of miR-34a-5p expression was confirmed, with the largest differences between normal GB and GBC organoids (<a href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure&#x000a0;1</span></a>F). Similarly, in a public miRNA microarray database using human resected specimens (<a id="__tag_1145776596" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE104165" ref="/geo/query/acc.cgi?acc=GSE104165"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE104165","term_id":"104165","extlink":"1"}}</span>GSE104165</a>),<a href="#bib26" rid="bib26" class=" bibr popnode"><sup>26</sup></a> miR-34a-5p expression levels showed the most significant decrease in GBC tissues compared to normal GB tissues (<a href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure&#x000a0;1</span></a>G). Based on these findings, we hypothesized that miR-34a-5p plays a pivotal role in GBC and could serve as a promising candidate for miRNA-based targeted therapy for GBC.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140714701622304"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10963938_gr1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10963938/bin/gr1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140714701622304"><a target="object" rel="noopener" href="/pmc/articles/PMC10963938/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC10963938/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Figure&#x000a0;1</a></div><!--caption a7--><div class="caption"><p>Differentially expressed miRNA identification in GBC-mimicking organoids</p><p>(A) Phase-contrast images (top) and H&#x00026;E (HE) staining (bottom) of pLKO.1-transduced control organoids (normal GB organoids) and GBC organoids (Cre-transduced organoids) derived from <em>Kras</em><sup>LSL-G12D/+</sup>; <em>Trp53</em><sup>f/f</sup> mice. Scale bars indicate 500&#x000a0;&#x003bc;m (top) and 50&#x000a0;&#x003bc;m (bottom). (B) Western blotting confirmed the Cre-mediated induction of Kras<sup>G12D</sup> and deletion of Trp53 in GBC organoids, with &#x003b2;-actin serving as a loading control. (C)&#x000a0;miRNA expression profiles in normal GB organoids and GBC organoids using miRNA microarrays. (D) Venn diagram showing the number of miRNAs exclusively or commonly detected in normal GB organoids (pLKO.1) and GBC organoids (Cre). (E)&#x000a0;Heatmap depicts 18 miRNAs with higher expression levels (log<sub>2</sub>FC&#x000a0;&#x0003e;&#x000a0;1) and 19 miRNAs with lower expression levels (log<sub>2</sub>FC&#x000a0;&#x0003c;&#x000a0;&#x02212;1) in GBC organoids compared with normal GB organoids. (F) The decreased expression levels of 4 miRNAs (miR-34a-5p, miR-181a-5p, miR-378a-3p, and miR-205-5p) in GBC organoids were confirmed by qRT-PCR. The miRNA expression levels were normalized to snoRNA202 expression levels. Data are presented as the mean&#x000a0;&#x000b1; SD (n&#x000a0;= 3). (G) The expression levels of miR-34a-5p showed the most significant decrease in human GBC tissues compared to those in normal GB tissues (log<sub>2</sub>FC&#x000a0;= &#x02212;2.50) in <a id="__tag_1145776594" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE104165" ref="/geo/query/acc.cgi?acc=GSE104165"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE104165","term_id":"104165","extlink":"1"}}</span>GSE104165</a>. The horizontal lines indicate the median values. &#x02217;p <em>&#x0003c;</em> 0.05; &#x02217;&#x02217;&#x02217;&#x02217;p <em>&#x0003c;</em> 0.0001.</p></div></div></div></div><div id="sec2.2" class="sec"><h3 id="sec2.2title">Forced miR-34a-5p expression inhibits cell proliferation and viability in GBC cell lines</h3><p id="p0035" class="p p-first-last">Three types of human GBC cell lines (G415, NOZ, and TGBC2TKB) were used for subsequent <em>in&#x000a0;vitro</em> studies. To explore the potential of miR-34a-5p as a therapeutic target for GBC, these cell lines were transfected with an miR-34a-5p mimic. Significant inhibition of cell proliferation in cells transfected with the mimic was observed compared to that in the negative control in 2D cell cultures (NOZ, p&#x000a0;&#x0003c;&#x000a0;0.01; G415 and TGBC2TKB, p <em>&#x0003c;</em> 0.05; <a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure&#x000a0;2</span></a>A) in a dose-dependent manner (<a href="#mmc1" rid="mmc1" class=" supplementary-material">Figure&#x000a0;S2</a>). These results suggest that forced miR-34a-5p expression can decrease the proliferation rate and viability of GBC cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140714701842048"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10963938_gr2.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10963938/bin/gr2.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140714701842048"><a target="object" rel="noopener" href="/pmc/articles/PMC10963938/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2">Figure&#x000a0;2</a></div><!--caption a7--><div class="caption"><p>miR-34a-5p inhibits the cell proliferation of GBC cells in 2D cell cultures</p><p>(A) Relative proliferation rate in human GBC cell lines after transfection with miR-34a-5p mimics was significantly suppressed compared to that in the negative control using an MTT assay. Data are presented as the means&#x000a0;&#x000b1; SDs (n <em>=</em> 3). &#x02217;p <em>&#x0003c;</em> 0.05; &#x02217;&#x02217;p <em>&#x0003c;</em> 0.01. (B) Cell-cycle arrest at the G1 phase was induced in GBC cell lines after transfection with miR-34a-5p mimics by flow cytometry. Representative images from 3 independent experiments are shown. (C) Potential target sequences in the 3&#x02032; UTR of cyclin D1 and CDK6 are shown. Target sequences (top sequences) and miR-34a-5p sequences (bottom sequences) were aligned with the highlighted complementary sequences at the seed sequences in miR-34a-5p using underlined text and bold font. (D) Western blot showing a reduction in cyclin D1 and CDK6 expression levels in GBC cell lines after transfection with miR-34a-5p mimics compared to the negative control. &#x003b2;-Actin was used as a loading control. Representative images from 3 independent experiments are shown. (E) The luciferase reporter constructs conjugated with the WT 3&#x02032; UTR sequences of <em>CDK6</em> or 3&#x02032; UTR sequences with MTs at possible target sequences were used. Sequences complementary to the seed sequences are indicated in red. miR-34a-5p significantly decreased the relative luciferase activity of the construct with the WT 3&#x02032; UTR sequences of <em>CDK6</em> in NOZ cells. Data from triplicate experiments are expressed as the mean&#x000a0;&#x000b1; SD. &#x02217;&#x02217;p <em>&#x0003c;</em> 0.01.</p></div></div></div></div><div id="sec2.3" class="sec"><h3 id="sec2.3title">Forced miR-34a-5p expression induces cell-cycle arrest at the G1 phase in GBC cell lines</h3><p id="p0040" class="p p-first-last">Mechanisms underlying these phenomena were determined by assessing the cell cycle. The miR-34a-5p mimic expression induced a remarkable increase in the percentage of cells in the G1 phase in all cell lines (<a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure&#x000a0;2</span></a>B). According to the miRDB database, <em>CDK6</em>, an important kinase for the G1/S transition, and <em>CCND1</em>, which forms a complex with and functions as a regulatory subunit of CDK6,<a href="#bib27" rid="bib27" class=" bibr popnode"><sup>27</sup></a> were identified as direct targets of miR-34a-5p (target scores: 92 and 58, respectively) (<a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure&#x000a0;2</span></a>C). The protein expression levels of CDK6 and cyclin D1 were substantially decreased in all three cell lines by forced expression of the miR-34a-5p mimic (<a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figures 2</span></a>D and <a href="#mmc1" rid="mmc1" class=" supplementary-material">S6</a>). These findings suggest that overexpression of miR-34a-5p induces cell-cycle arrest at the G1 phase, at least partly by downregulating the expression of CDK6 and cyclin D1, leading to cell proliferation inhibition in GBC cell lines.</p></div><div id="sec2.4" class="sec"><h3 id="sec2.4title">CDK6 is a direct target of miR-34a-5p</h3><p id="p0045" class="p p-first-last">To further explore whether the 3&#x02032; UTR of <em>CDK6</em> is a direct target of miR-34a-5p, luciferase-based reporters were used (<a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure&#x000a0;2</span></a>E). Cotransfection of NOZ cells with the reporter construct containing the wild-type (WT) or mutant-type (MT) <em>CDK6</em> 3&#x02032; UTR sequences at the downstream of the luciferase gene and the miR-34a-5p mimic resulted in a significant decrease in luciferase activity compared to cells transfected with the negative control mimic, only when using the reporter construct with WT <em>CDK6</em> 3&#x02032; UTR sequences (p&#x000a0;&#x0003c;&#x000a0;0.01; <a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure&#x000a0;2</span></a>E). These results, together with the marked decrease in CDK6 expression in GBC cells transfected with the miR-34a-5p mimic (<a href="/pmc/articles/PMC10963938/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure&#x000a0;2</span></a>D), indicated that miR-34a-5p predominantly inhibits the cell cycle and cell proliferation, partially via direct CDK6 downregulation in GBC cells.</p></div><div id="sec2.5" class="sec"><h3 id="sec2.5title">Differentially expressed gene (DEG) enrichment related to cell cycle by miR-34a-5p expression in GBC cells</h3><p id="p0050" class="p p-first-last">To determine the transcriptomic differences between control and miR-34a-5p mimic-transfected GBC cell lines, RNA samples from paired NOZ cells were used for RNA sequencing (RNA-seq) analyses. The principal-component analysis plot showed distinct clustering between NOZ cells transfected with miR-34a-5p and negative controls (<a href="#mmc1" rid="mmc1" class=" supplementary-material">Figure&#x000a0;S3</a>). Compared to the control, miR-34a-5p-transfected NOZ cells exhibited 2,437 significant DEGs, with 927 upregulated and 1,037 downregulated genes (<a href="/pmc/articles/PMC10963938/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure&#x000a0;3</span></a>A). As expected, the downregulated genes showed the most significant association with the miR-34a-5p target genes, as determined by enrichment analysis and gene set enrichment analysis (GSEA) (<a href="/pmc/articles/PMC10963938/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure&#x000a0;3</span></a>B, false discovery rate [FDR]&#x000a0;= 9.7e&#x02212;20; <a href="/pmc/articles/PMC10963938/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure&#x000a0;3</span></a>C, p&#x000a0;= 6.99e&#x02212;08). Known miR-34a-5p target gene expressions such as <em>Snail1</em> (target score: 94), <em>BIRC5</em> (score not shown),<a href="#bib28" rid="bib28" class=" bibr popnode"><sup>28</sup></a>
<em>Notch2</em> (target score: 84) and <em>CDK6</em> were significantly decreased (<a href="#mmc1" rid="mmc1" class=" supplementary-material">Figure&#x000a0;S4</a>). Furthermore, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of these genes revealed a significant enrichment of biological processes related to the inhibition of the cell cycle and G1-to-S-phase transition (<a href="/pmc/articles/PMC10963938/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figures&#x000a0;3</span></a>D and 3E, adjusted p&#x000a0;= 3.28e&#x02212;08; <a href="#mmc1" rid="mmc1" class=" supplementary-material">Figure&#x000a0;S5</a>), which is consistent with the aforementioned results showing the inhibition of cell-cycle progression and proliferation in miR-34a-5p-transfected GBC cell lines.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC10963938/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140714693944592"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10963938_gr3.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10963938/bin/gr3.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140714693944592"><a target="object" rel="noopener" href="/pmc/articles/PMC10963938/figure/fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC10963938/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3">Figure&#x000a0;3</a></div><!--caption a7--><div class="caption"><p>Enrichment of gene sets related to cell-cycle regulation in the miR-34a-5p mimic-transfected GBC cells</p><p>(A) Heatmap showing hierarchical clustering based on DEG expression in miR-34a-5p-transfected cells (n&#x000a0;= 3) and controls (n&#x000a0;= 3). DEGs were identified with an FDR&#x000a0;&#x0003c;&#x000a0;0.01 and an absolute FC &#x0003e;2. (B) The downregulated genes exhibited significant enrichment in the miR-34a-5p target gene set, as evidenced by enrichment analyses (FDR&#x000a0;= 9.7e&#x02212;20). The most enriched miRNA target genes along with their FDR and gene counts are listed. (C) GSEA plot demonstrating the enrichment of miR-34a-5p target gene sets in miR-34a-5p-transfected GBC cells compared to the negative control (p&#x000a0;= 6.99e&#x02212;08). (D) GSEA results demonstrate significant enrichment of gene sets related to the cell cycle following the miR-34a-5p-transfection. The most enriched biological processes, along with their p values and gene counts, are presented. (E) GSEA plot demonstrating the enrichment of cell-cycle-related gene sets in miR-34a-5p-transfected GBC cells compared to the negative control (adjusted p&#x000a0;= 3.28e&#x02212;08).</p></div></div></div></div><div id="sec2.6" class="sec sec-last"><h3 id="sec2.6title">miR-34a-5p suppresses GBC growth in the murine xenograft model</h3><p id="p0055" class="p p-first-last">To confirm the suppressive function of miR-34a-5p in GBC <em>in&#x000a0;vivo</em>, we used a GBC xenograft model. When the average size of the subcutaneously implanted tumors reached &#x0223c;80&#x000a0;mm<sup>3</sup>, a mixture of miR-34a-5p or a negative control with atelocollagen was injected around the tumors every 4&#x02013;5&#x000a0;days for 3&#x000a0;weeks (<a href="/pmc/articles/PMC10963938/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Figure&#x000a0;4</span></a>A). Compared to the negative controls, miR-34a-5p significantly inhibited GBC tumor growth after five injections (<a href="/pmc/articles/PMC10963938/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Figures&#x000a0;4</span></a>A and 4B). miR-34a-5p injection significantly decreased the CDK6 expression levels in the tumors compared to those in the negative control (<a href="/pmc/articles/PMC10963938/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Figure&#x000a0;4</span></a>C), suggesting that forced expression of miR-34a-5p by direct injection also has the potential to suppress GBC growth <em>in&#x000a0;vivo</em>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC10963938/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140714700330560"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10963938_gr4.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10963938/bin/gr4.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140714700330560"><a target="object" rel="noopener" href="/pmc/articles/PMC10963938/figure/fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC10963938/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4">Figure&#x000a0;4</a></div><!--caption a7--><div class="caption"><p>Local miR-34a-5p administration suppresses GBC growth <em>in&#x000a0;vivo</em></p><p>(A) Subcutaneous miR-34a-5p mimic or negative control with atelocollagen injection around the NOZ tumor was repeated every 4 or 5&#x000a0;days, for a total of 5 sessions. Error bars indicate the mean&#x000a0;&#x000b1; SD; n&#x000a0;= 5 mice per group. (B)&#x000a0;miR-34a-5p mimics significantly suppressed tumor growth compared to the negative control. Macroscopic images of tumors from each group after 5 injections over 21&#x000a0;days are shown. The scale bar indicates 10&#x000a0;mm. (C) IHC staining of CDK6 protein expression (brown in the&#x000a0;nucleus) in harvested subcutaneous tumors after 5&#x000a0;injections for 21&#x000a0;days (left). The scale bar indicates 50&#x000a0;&#x003bc;m. The injection of miR-34a-5p mimics significantly decreased the expression levels of CDK6 protein. Error bars represent the mean&#x000a0;&#x000b1; SD (n&#x000a0;= 3 in each group) (right). &#x02217;p <em>&#x0003c;</em> 0.05.</p></div></div></div></div></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">Discussion</h2><p id="p0060" class="p p-first">Because only a small number of therapeutic options are currently available for GBC, novel therapeutic development is urgently required. In this study, we uncovered the vital role of miR-34a-5p in GBC and determined that miR-34a-5p forced expression leads to efficient GBC progression suppression via cell-cycle inhibition, at least partly by <em>CDK6</em> downregulation, a direct target of this miRNA.</p><p id="p0065">The 3D organoid culture system has been established as a physiological model that closely mimics the structure and differentiation that occur in the body compared to 2D culture systems. In particular, these organoid models have enabled us to culture primary normal epithelial cells for a long time, including normal GB cells, and have therefore led us to precisely compare GBC and normal GB <em>in&#x000a0;vitro</em>. Owing to the lack of genetically modified murine models for GBC presently, normal GB organoids and GBC organoids induced by <em>Kras</em> activation and <em>Trp53</em> loss with Cre expression used here present attractive alternatives for GBC studies. Although the induction of an oncogene and/or the regulation of a tumor suppressor gene in normal epithelial cells does not necessarily lead to tumorigenicity,<a href="#bib16" rid="bib16" class=" bibr popnode"><sup>16</sup></a> it has already been confirmed that Cre-induced GBC organoids were actually tumorigenic when inoculated subcutaneously into mice, but normal GB organoids were not tumorigenic.<a href="#bib16" rid="bib16" class=" bibr popnode"><sup>16</sup></a> Therefore, these organoids present promising tools for assessing the biology of GBC.</p><p id="p0070">In this study, several miRNAs were found to be differentially expressed in GBC, including miR-34a-5p. Although miR-34a-5p is transcriptionally activated by <em>TP53</em>,<a href="#bib29" rid="bib29" class=" bibr popnode"><sup>29</sup></a><sup>,</sup><a href="#bib30" rid="bib30" class=" bibr popnode"><sup>30</sup></a> the miR-34a expression is also regulated by other mechanisms, such as CpG methylation of its promoter region,<a href="#bib31" rid="bib31" class=" bibr popnode"><sup>31</sup></a> sponge effects of long noncoding RNA,<a href="#bib32" rid="bib32" class=" bibr popnode"><sup>32</sup></a><sup>,</sup><a href="#bib33" rid="bib33" class=" bibr popnode"><sup>33</sup></a> and chromosomal deletion.<a href="#bib24" rid="bib24" class=" bibr popnode"><sup>24</sup></a> Therefore, its expression is likely not solely dependent on p53 status but also on other factors. <em>TP53</em> mutations are identified in over 40%&#x02013;60% of GBC cases, establishing it as one of the predominant driver mutations for GBC.<a href="#bib3" rid="bib3" class=" bibr popnode"><sup>3</sup></a><sup>,</sup><a href="#bib34" rid="bib34" class=" bibr popnode"><sup>34</sup></a> In addition, significantly decreased expression levels of miR-34a-5p were observed in most GBC tissues, as deduced from the results deposited in public databases, and the overexpression of miR-34a-5p resulted in growth inhibition in GBC cell lines, even those with WT <em>TP53</em>, such as G415 cells. Further examination using GB and GBC organoids with WT p53 may be necessary to determine the biological significance of miR-34a-5p in GBC in such cases.</p><p id="p0075">miR-34a-5p is downregulated in a wide range of solid tumors and hematological malignancies.<a href="#bib25" rid="bib25" class=" bibr popnode"><sup>25</sup></a> Specifically, miR-34a-5p directly regulates several target mRNAs encoding proteins related to cell-cycle transition (<em>CCND1</em>, <em>CDK6</em>, <em>Notch1</em>, and <em>Notch2</em>),<a href="#bib27" rid="bib27" class=" bibr popnode"><sup>27</sup></a><sup>,</sup><a href="#bib35" rid="bib35" class=" bibr popnode"><sup>35</sup></a> apoptosis (<em>Bcl-2</em> and <em>BIRC5</em>),<a href="#bib36" rid="bib36" class=" bibr popnode"><sup>36</sup></a><sup>,</sup><a href="#bib37" rid="bib37" class=" bibr popnode"><sup>37</sup></a><sup>,</sup><a href="#bib38" rid="bib38" class=" bibr popnode"><sup>38</sup></a><sup>,</sup><a href="#bib39" rid="bib39" class=" bibr popnode"><sup>39</sup></a> migration, and invasion (<em>Snail</em> and <em>Notch1</em>),<a href="#bib40" rid="bib40" class=" bibr popnode"><sup>40</sup></a><sup>,</sup><a href="#bib41" rid="bib41" class=" bibr popnode"><sup>41</sup></a><sup>,</sup><a href="#bib42" rid="bib42" class=" bibr popnode"><sup>42</sup></a><sup>,</sup><a href="#bib43" rid="bib43" class=" bibr popnode"><sup>43</sup></a> resulting in the repression of tumor progression. In the context of GBC, only a few studies have reported the relationship between miR-34a-5p and GBC. For example, the low expression of miR-34a, which extends telomere length, is a useful biomarker for predicting poor prognosis in patients with GBC.<a href="#bib19" rid="bib19" class=" bibr popnode"><sup>19</sup></a> In this study, we revealed that miR-34a-5p overexpression, as a therapeutic option, induced strong gene set enrichment of&#x000a0;cell-cycle regulators with decreased expression levels related to cell proliferation, the epithelial-mesenchymal transition, and survival (e.g., <em>CDK6</em>, <em>BIRC5</em>, <em>Snail1</em>, and <em>Notch2</em>) in GBC cell lines and murine xenograft models. Thus, we strongly suggest that GBC cell growth inhibition by miR-34a-5p can aid in the development of therapeutic strategies for treating aggressive GBC.</p><p id="p0080">Regarding the clinical application of miR-34a-5p supplementation, a&#x000a0;liposomal miR-34a mimic, MRX34, has been developed, and the results of a Phase I study, in which patients with advanced solid tumors received MRX34 intravenously, were reported in 2020.<a href="#bib44" rid="bib44" class=" bibr popnode"><sup>44</sup></a> Although the disease control rate was 29% in that study, the trial was closed early owing to four patient deaths with unexpected severe immune-mediated toxicities. Thus, specific drug delivery systems (DDSs) that avoid or minimize nonspecific delivery to other normal tissues require further elucidation.<a href="#bib45" rid="bib45" class=" bibr popnode"><sup>45</sup></a> Alternatively, in current clinical practice, endoscopic ultrasonography-guided injections can be performed for GB lesions.<a href="#bib46" rid="bib46" class=" bibr popnode"><sup>46</sup></a> Therefore, local miR-34a-5p supplementation, with or without systemic chemotherapy, may be a realistic option for clinicians to apply the results obtained in clinical settings.</p><p id="p0085" class="p p-last">In conclusion, although further optimization is required, our <em>in&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em> analyses revealed that forced expression of miR-34a-5p presents a promising therapeutic option for patients with GBC.</p></div><div id="sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4title">Materials and methods</h2><div id="sec4.1" class="sec sec-first"><h3 id="sec4.1title">Organoid-based GB carcinogenesis model</h3><p id="p0090" class="p p-first-last">Cre-transduced and pLKO.1-, a negative control construct, transduced GB organoids derived from <em>Kras</em><sup>LSL-G12D/+</sup>; <em>Trp53</em><sup>f/f</sup> mice (a gift from Dr. Yoshitaka Hippo, Chiba Cancer Center Research Institute, Chiba, Japan). Detailed protocols for establishment and characterization have been described previously.<a href="#bib16" rid="bib16" class=" bibr popnode"><sup>16</sup></a> Briefly, the GB was isolated from <em>Kras</em><sup>LSL-G12D/+</sup>; <em>Trp53</em><sup>f/f</sup> mice, and normal GB organoids were established from these cells. Lentivirus-expressing Cre cells were transduced into GB organoids <em>in&#x000a0;vitro</em> to establish GBC organoids. The tumorigenicity of the Cre-transduced GB organoids was confirmed by subcutaneously inoculating the organoids into nude mice, after which aggressively growing nodules were observed. Furthermore, the nodules were excised, and subsequent organoid cultures were established after the dissociation of the recovered tumor-derived epithelial cells. These tumor-derived organoids were used as Cre<em>-</em>transduced GB organoids to model GBC.<a href="#bib16" rid="bib16" class=" bibr popnode"><sup>16</sup></a> Advanced DMEM/F12 (Thermo Fisher Scientific, Waltham, MA) media containing <span class="small-caps">l</span>-glutamine, penicillin, streptomycin, and amphotericin B, supplemented with 50&#x000a0;ng/mL epidermal growth factor (Peprotech, Rocky Hill, NJ), 100&#x000a0;ng/mL Noggin (Peprotech), 1&#x000a0;&#x003bc;M Jagged1 (AnaSpec, Fremont, CA), and 10&#x000a0;&#x003bc;M Y27632 (Wako, Osaka, Japan), were used with the Matrigel (no. 354234, Corning, Corning, NY) to culture organoids.</p></div><div id="sec4.2" class="sec"><h3 id="sec4.2title">Comprehensive miRNA expression analyses</h3><p id="p0095" class="p p-first-last">For analysis, the Matrigel was lysed with Cell Recovery Solution (BD Biosciences, San Jose, CA) and washed with PBS to collect pure, viable organoid populations. Total RNA was extracted from these organoids using the 3D-Gene RNA Extraction Reagent (Toray Industries, Tokyo, Japan), and quality checked using an Agilent RNA 6000 Pico Kit and an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Comprehensive miRNA expression analyses were performed using the 3D-Gene miRNA Labeling Kit and the 3D-Gene Mouse miRNA Oligo Chip (version 21; Toray Industries), as previously described.<a href="#bib47" rid="bib47" class=" bibr popnode"><sup>47</sup></a> Fluorescent signals were scanned using a 3D-Gene Scanner 3000 and analyzed using 3D-Gene Extraction software (Toray Industries). The global normalization method was applied to background-subtracted signal intensities, setting the median of these signal intensities to 25.0. The FC values of Cre-transduced GB organoids for each miRNA were calculated using signals from pLKO.1<em>-</em>transduced GB organoids as reference.</p></div><div id="sec4.3" class="sec"><h3 id="sec4.3title">Cell culture and miRNA transfection</h3><p id="p0100" class="p p-first">Human GBC cell lines G415, NOZ, and TGBC2TKB were obtained from Tohoku University (Sendai, Japan), the Japanese Collection of Research Bioresources cell bank (Osaka, Japan), and the RIKEN cell bank (Tsukuba, Japan), respectively. The NOZ cell line was established by Dr. S. Nagamori (National Institute of Infectious Diseases, Tokyo, Japan).<a href="#bib48" rid="bib48" class=" bibr popnode"><sup>48</sup></a> G415 cells were cultured in RPMI 1640 (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS), NOZ cells in Williams&#x02019; Medium E (Thermo Fisher Scientific) supplemented with 10% FBS and <span class="small-caps">l</span>-glutamine, and TGBC2TKB cells in DMEM (Thermo Fisher Scientific) containing low glucose and supplemented with 5% FBS. All of the cells were cultured in a humidified atmosphere containing 5% CO<sub>2</sub> at 37&#x000b0;C.</p><p id="p0105" class="p p-last">Cells were seeded at 2&#x02013;3&#x000a0;&#x000d7;&#x000a0;10<sup>4</sup> cells/well in a 24-well plate, precultured in medium containing 5%&#x02013;10% FBS up to 60% confluence, and then transfected with 3, 5, 10, or 20&#x000a0;nM of either mirVana miRNA mimic (hsa-miR-34a-5p [MC11030] or negative control no. 1 4464058) (Thermo Fisher Scientific) using Lipofectamine RNAiMAX Transfection Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer&#x02019;s protocol. The cells were cultured for 48&#x02013;72&#x000a0;h and used for downstream assays.</p></div><div id="sec4.4" class="sec"><h3 id="sec4.4title">2D cell culture viability and cell proliferation assays</h3><p id="p0110" class="p p-first-last">Cell proliferation and viability were determined in 2D cells using an&#x000a0;MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Briefly, treated cells were seeded in 96-well plates at a density of 2&#x000a0;&#x000d7;&#x000a0;10<sup>3</sup> or 2.5&#x000a0;&#x000d7;&#x000a0;10<sup>3</sup> cells/well, depending on the cell line. After 24, 48, 72, and 96&#x000a0;h of incubation, MTT (0.5&#x000a0;mg/mL in the medium) was added to each well. The cells were then incubated for 3&#x000a0;h at 37&#x000b0;C, and the purple-blue formazan precipitate was dissolved using 200&#x000a0;&#x003bc;L DMSO. Absorbance was measured at 570&#x000a0;nm using a microplate reader (MULTISKAN GO, Thermo Fisher Scientific). Media containing the MTT reagent but without cells were used as a blank control. All of the experiments were performed in triplicate (minimum).</p></div><div id="sec4.5" class="sec"><h3 id="sec4.5title">Cell-cycle analysis</h3><p id="p0115" class="p p-first-last">The treated cells were collected and fixed in 70% ethanol at 4&#x000b0;C for 2 h. The cells were then washed with PBS and stained with 20&#x000a0;&#x003bc;g/mL propidium iodide containing 0.25&#x000a0;mg/mL RNase for 30&#x000a0;min in a dark environment at 37&#x000b0;C. Finally, the cells in each cell-cycle phase&#x000a0;were assayed using a MACS Quant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany), and the percentage of cells in the G1, S, and G2/M phases was determined using FlowJo version 10 software (BD Biosciences, Ashland, OR).</p></div><div id="sec4.6" class="sec"><h3 id="sec4.6title">qRT-PCR</h3><p id="p0120" class="p p-first">Total RNA was extracted from the organoids or cell lines using an miRNeasy Micro Kit (Qiagen, Valencia, CA) according to the manufacturer&#x02019;s instructions. RNA samples were reverse transcribed using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) with TaqMan MicroRNA Assay (Thermo Fisher Scientific). Subsequently, qPCR was performed using the TaqMan Fast Advanced Master Mix (Applied Biosystems) and the LightCycler 96 Real-Time PCR System (Roche, Basel, Switzerland) in 96-well plates. The analysis of relative gene expression data was calculated using the 2<sup>&#x02212;&#x00394;&#x00394;Cq</sup> method.<a href="#bib49" rid="bib49" class=" bibr popnode"><sup>49</sup></a> All of the reactions were performed in duplicate.</p><p id="p0125" class="p p-last">The following TaqMan miRNA assays were performed: mmu (hsa)-miR-34a-5p (000426), mmu-miR-181a-5p (000480), mmu-miR-205-5p (000509), mmu-miR-378a-3p (002243), snoRNA202 (001232), and RNU6B (001093). Results were normalized to snoRNA202 and RNU6B expression levels in RNA samples derived from mice and <em>Homo sapiens</em>, respectively.</p></div><div id="sec4.7" class="sec"><h3 id="sec4.7title">Western blotting</h3><p id="p0130" class="p p-first-last">After transfection with the miR-34a-5p mimic or negative control mimic for 48 or 72 h, protein lysates were harvested using radioimmunoprecipitation assay buffer (89900; Thermo Fisher Scientific) with protease inhibitors. The bicinchoninic acid method (23225; Thermo Fisher Scientific) was used to measure the protein concentration. Harvested cell protein (10&#x000a0;&#x003bc;g) was resolved using SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad, Hercules, CA) using semidry transfer. The membranes were blocked using a PVDF blocking reagent (Can Get Signal; Toyobo, Osaka, Japan) for 1 h. Reactive bands were detected using Clarity Western ECL Substrate (no. 1705060; Bio-Rad) and ImageQuant LAS 4000 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The primary antibodies used in this study were against RasG12D (no. 14429, Cell Signaling Technology, Danvers, MA), p53 (no. 2524, Cell Signaling Technology), CDK6 (#3136, Cell Signaling Technology), cyclin D1 (no. 2922, Cell Signaling Technology), and &#x003b2;-actin (no. 4967, Cell Signaling Technology). Horseradish peroxidase-conjugated anti-mouse immunoglobulin G (IgG) (no. 7076, Cell Signaling Technology) or anti-rabbit IgG (no. 7074, Cell Signaling Technology) were used as secondary antibodies.</p></div><div id="sec4.8" class="sec"><h3 id="sec4.8title">Immunohistochemistry (IHC)</h3><p id="p0135" class="p p-first-last">Organoid Matrigels were first depolymerized by Cell Recovery Solution and then embedded in iPGell (GenoStaff, Tokyo, Japan), followed by formalin fixation. Harvested subcutaneous tumor specimens were formalin fixed, paraffin embedded, and sectioned at 4&#x000a0;&#x003bc;m. H&#x00026;E staining was used for histological analysis. For IHC analysis, tissue sections were deparaffinized and soaked in 0.3% H<sub>2</sub>O<sub>2</sub> in methanol at room temperature for 10&#x000a0;min to block endogenous peroxidase activity. Antigen retrieval was performed by heating the specimens in 10&#x000a0;mM sodium citrate buffer (pH 6.0) using a microwave. After three 5-min washes with PBS, the tissue sections were incubated with a primary antibody against CDK6 (sc-7961; Santa Cruz Biotechnology, Dallas, TX) at room temperature for 30&#x000a0;min (1:200 dilution). After another three 5-min washes with PBS, the sections were incubated with secondary anti-mouse IgG (K4001; Agilent Technologies, Santa Clara, CA) for 30&#x000a0;min at room temperature. 3,3&#x02032;-Diaminobenzidine+ (K3468, Agilent Technologies) was used as the chromogen, and the nuclei were counterstained with Mayer&#x02019;s hematoxylin. CDK6 IHC slides were scanned using an Axio Scan.Z1 (Zeiss, Jena, Germany). The resulting whole-slide images were imported into an open-source software program (QuPath version 0.3.2) for viewing and assessment. Furthermore, a digital assistance tool was developed using QuPath&#x02019;s positive cell detection algorithm and used for the assessment.<a href="#bib50" rid="bib50" class=" bibr popnode"><sup>50</sup></a></p></div><div id="sec4.9" class="sec"><h3 id="sec4.9title">RNA-seq</h3><p id="p0140" class="p p-first">Total RNA was isolated from NOZ cells treated with 5&#x000a0;nM miR-34a-5p mimic or negative control mimic 48&#x000a0;h after transfection. Three biological replicates were used for each sample (n&#x000a0;= 3). The RNA quality was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies), and RNAs with an RNA integrity number above nine were processed for sequencing. Libraries were constructed using the NEBNext Ultra II Directional RNA Library Prep Kit (New England Biolabs, Ipswich, MA) according to the manufacturer&#x02019;s instructions. Then, 150-bp paired-end sequencing was performed using an Illumina NovaSeq 6000 instrument (Illumina, San Diego, CA). Raw sequence data were filtered using Fastp (version 0.19.5) to remove adapter sequences and low-quality or short reads. The filtered data were aligned with the human reference genome (GRCh38.p13) using the STAR software (version 2.7.10a). Gene expression counts were summed using RSEM software (version 1.3.1).</p><p id="p0145" class="p p-last">The DEGs obtained from RNA-seq-based expression profiling were analyzed using the integrated Differential Expression and Pathway analysis online tools. DESeq2 results were used for differential expression analysis, and genes with an FDR&#x000a0;&#x0003c;&#x000a0;0.01 and an absolute FC&#x000a0;&#x0003e;&#x000a0;2 identified by DESeq2 were designated DEGs. The DEGs were then used to generate a heatmap after converting the data to base two logarithms and <em>Z</em> scores. The heatmap function of the ComplexHeatmap package (version 2.14) was used with R software (version 4.2.1; <a href="https://www.r-project.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.r-project.org/</a>). The relationship between DEGs and miRNAs was assessed using miRTarBase,<a href="#bib51" rid="bib51" class=" bibr popnode"><sup>51</sup></a> and enrichment analysis was conducted using ShinyGO 0.77.<a href="#bib52" rid="bib52" class=" bibr popnode"><sup>52</sup></a> GSEA was performed using the clusterProfiler R package, KEGG pathway, and WikiPathway databases.<a href="#bib53" rid="bib53" class=" bibr popnode"><sup>53</sup></a></p></div><div id="sec4.10" class="sec"><h3 id="sec4.10title">Dual luciferase reporter assay</h3><p id="p0150" class="p p-first-last">Plasmids were constructed using the pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega, Madison, WI) for the binding site in the 3&#x02032; UTR of the potential target gene (<em>CDK6</em>) based on the miRNA target prediction database, miRDB.<a href="#bib54" rid="bib54" class=" bibr popnode"><sup>54</sup></a> For the reported gene assay, NOZ cells (5&#x000a0;&#x000d7;&#x000a0;10<sup>3</sup> cells) were cotransfected with reporter vectors <em>(CDK6</em> WT or <em>CDK6</em> MT), miR-34a-5p mimic, and negative control mimic using Lipofectamine 3000 Reagent (Invitrogen) on the Corning 96 Half Area Well Solid White Flat Bottom Polystyrene Tissue Culture-treated microplates (no. 3688; Corning). Following transfection for 72 h, luciferase activity was evaluated using the Nano-Glo Dual-Luciferase Reporter Gene Assay System (Promega) and GloMax Discover Microplate Reader (Promega). Normalization was performed using Renilla luciferase as the reference standard. All of the experiments were conducted in triplicate.</p></div><div id="sec4.11" class="sec"><h3 id="sec4.11title"><em>In&#x000a0;vivo</em> experiments in mice bearing human tumor xenograft</h3><p id="p0155" class="p p-first">For the <em>in&#x000a0;vivo</em> model, NOZ cells (3&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells) were subcutaneously injected into the flank regions of 6-week-old BALB/c nu/nu mice. Ten days later, local treatment with synthetic miRNAs prepared using atelocollagen as the DDS was initiated. Briefly, a mixture of miRNA-atelocollagen was prepared using either 1&#x000a0;nmol of the miR-34a-5p (HMI0508; Sigma-Aldrich, Saint Louis, MO) or 1&#x000a0;nmol of the negative control miRNA (HMC0003; Sigma-Aldrich) and an AteloGene Local Use &#x0201c;Quick Gelatin&#x0201d; kit (KOKEN, Tokyo, Japan), according to the manufacturer&#x02019;s protocol.<a href="#bib55" rid="bib55" class=" bibr popnode"><sup>55</sup></a><sup>,</sup><a href="#bib56" rid="bib56" class=" bibr popnode"><sup>56</sup></a> The mixture was injected around the tumor site five times over 3&#x000a0;weeks. The tumor volume was calculated using the following formula: V&#x000a0;= A&#x000a0;&#x000d7;&#x000a0;B<sup>2</sup>/2 (mm<sup>3</sup>), where A is the largest diameter (mm) and B is the smallest diameter (mm). At 35&#x000a0;days after tumor cell implantation, the mice were euthanized, and the tumors were collected for further analysis.</p><p id="p0160" class="p p-last">The synthesized miRNA mimics used for <em>in&#x000a0;vivo</em> experiments were as follows: hsa-miR-34a-5p mimic (sense, 5&#x02032;-[AmC6]ACAACCAGCUAAGACACUGUCCA[dT][dT]-3&#x02032;; antisense, 5&#x02032;-UGGCAGUGUCUUAGCUGGUUGU-3&#x02032;), and negative control miRNA (sense, 5&#x02032;-[AmC6]GAUAUCCCGCCGCGAUCGUAUCCG[dT][dT]-3&#x02032;; antisense, 5&#x02032;-CGGUACGAUCGCGGCGGGAUAUC-3&#x02032;). The animal protocol was approved by the Animal Care and Use Committee of Okayama University (approval no. OKU-2021537). All of the experiments were conducted in strict accordance with the Policy on the Care and Use of Laboratory Animals at Okayama University.</p></div><div id="sec4.12" class="sec"><h3 id="sec4.12title">Bioinformatics analyses</h3><p id="p0165" class="p p-first-last">To investigate the miRNA expression in human tissue, we searched the GEO database for datasets using the keywords &#x0201c;gallbladder carcinoma&#x0201d; and &#x0201c;miRNA.&#x0201d; We used the <a id="__tag_1145776599" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE104165" ref="/geo/query/acc.cgi?acc=GSE104165"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE104165","term_id":"104165","extlink":"1"}}</span>GSE104165</a> dataset and the GEO2R online analysis tool to determine the expression levels of miRNAs of interest in GBC and normal tissues. The targets of these miRNAs were identified using the miRDB online database.<a href="#bib54" rid="bib54" class=" bibr popnode"><sup>54</sup></a></p></div><div id="sec4.13" class="sec sec-last"><h3 id="sec4.13title">Statistical analyses</h3><p id="p0170" class="p p-first-last">All of the statistical analyses were performed using JMP Pro 15.1.0 (SAS Institute, Cary, NC) or GraphPad Prism 9.3.1 (GraphPad, San&#x000a0;Diego, CA). Group comparisons were performed using the Kruskal-Wallis, Mann-Whitney <em>U</em>, Pearson chi-square, or Wilcoxon rank-sum tests. All of the tests were two-sided. p&#x000a0;&#x0003c;&#x000a0;0.05 were considered statistically significant.</p></div></div><div id="sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5title">Data and code availability</h2><p id="p0175" class="p p-first-last">All of the data, materials, and protocols used in this study are available from the corresponding author upon reasonable request.</p></div><div id="ack0010" class="tsec sec"><h2 class="head no_bottom_margin" id="ack0010title">Acknowledgments</h2><div class="sec"><p id="p0180">We thank Dr. Yoshitaka Hippo for providing the Cre- and pLKO.1-transduced GB organoids. We thank Ms. Yuki Osaki for technical support. This work was supported in part by JSPS KAKENHI (grant nos. 21K07962 to H.K., 22K08032 to K.T., and 22H02828 to M.O.) from the Japan Society for the Promotion of Science and an Okayama Health Foundation Cancer Research Grant (to K.T.).</p><div id="sec6" class="sec"><h3 id="sec6title">Author contributions</h3><p id="p0185" class="p p-first-last">Conception and design, K.T. Collection and assembly of data, T. Oda and K.T. Data analysis and interpretation, T. Oda, K.T., T. Obata, E.U., T.K., S.A., R.C., and M.O. Provision of resources, Y.F., T.Y., D.U., K.M., S.H., H.K., and H.O. Writing&#x000a0;&#x02013; original draft, T. Oda. Writing&#x000a0;&#x02013; review&#x000a0;&#x00026; editing, K.T., T. Obata, E.U., T.K., S.A., Y.F., T.Y., D.U., K.M., S.H., H.K., H.O., R.C., and M.O. Supervision, K.T. and M.O.</p></div><div id="sec7" class="sec sec-last"><h3 id="sec7title">Declaration of interests</h3><p id="p0190" class="p p-first-last">The authors declare no competing interests.</p></div></div></div><div id="fn-group-a.l.d" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.l.dtitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="appsec1"><p id="p0195" class="p p-first-last">Supplemental information can be found online at <a href="https://doi.org/10.1016/j.omton.2024.200765" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://doi.org/10.1016/j.omton.2024.200765</a>.</p></p></div></div><div id="appsec2" class="tsec bk-sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="appsec2title">Supplemental information</h2><!--/article/back/sec/--><p id="p0200" class="p p-first-last">
</p><div class="sec suppmat" id="mmc1"><!--caption a9--><strong>Document S1. Figures&#x000a0;S1&#x02012;S6:</strong><div class="sup-box half_rhythm" id="media-a.l.b.b.a.b"><a href="/pmc/articles/PMC10963938/bin/mmc1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(706K, pdf)</sup></div></div><p>
</p><div class="sec suppmat" id="mmc2"><!--caption a9--><strong>Document S2. Article plus supplemental information:</strong><div class="sup-box half_rhythm" id="media-a.l.b.b.b.b"><a href="/pmc/articles/PMC10963938/bin/mmc2.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(4.2M, pdf)</sup></div></div><p>
</p></div><div id="cebib0010" class="tsec sec"><h2 class="head no_bottom_margin" id="cebib0010title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="bib1">1. <span class="element-citation" id="sref1">Sharma A., Sharma K.L., Gupta A., Yadav A., Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. <span><span class="ref-journal">World J. Gastroenterol. </span>2017;<span class="ref-vol">23</span>:3978–3998.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5473118/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28652652" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J.+Gastroenterol.&amp;title=Gallbladder+cancer+epidemiology,+pathogenesis+and+molecular+genetics:+Recent+update&amp;author=A.+Sharma&amp;author=K.L.+Sharma&amp;author=A.+Gupta&amp;author=A.+Yadav&amp;author=A.+Kumar&amp;volume=23&amp;publication_year=2017&amp;pages=3978-3998&amp;pmid=28652652&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib2">2. <span class="element-citation" id="sref2">American Cancer Society  . 2018. Cancer Facts&#x000a0;&#x00026; Figures&#x000a0;2018. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=American+Cancer+Society+Cancer+Facts&#x000a0;&#x00026;+Figures&#x000a0;2018+2018+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib3">3. <span class="element-citation" id="sref3">Nakamura H., Arai Y., Totoki Y., Shirota T., Elzawahry A., Kato M., Hama N., Hosoda F., Urushidate T., Ohashi S., et al. Genomic spectra of biliary tract cancer. <span><span class="ref-journal">Nat. Genet. </span>2015;<span class="ref-vol">47</span>:1003–1010.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26258846" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Genet.&amp;title=Genomic+spectra+of+biliary+tract+cancer&amp;author=H.+Nakamura&amp;author=Y.+Arai&amp;author=Y.+Totoki&amp;author=T.+Shirota&amp;author=A.+Elzawahry&amp;volume=47&amp;publication_year=2015&amp;pages=1003-1010&amp;pmid=26258846&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib4">4. <span class="element-citation" id="sref4">Zou S., Li J., Zhou H., Frech C., Jiang X., Chu J.S.C., Zhao X., Li Y., Li Q., Wang H., et al. Mutational landscape of intrahepatic cholangiocarcinoma. <span><span class="ref-journal">Nat. Commun. </span>2014;<span class="ref-vol">5</span>:5696.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25526346" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Commun.&amp;title=Mutational+landscape+of+intrahepatic+cholangiocarcinoma&amp;author=S.+Zou&amp;author=J.+Li&amp;author=H.+Zhou&amp;author=C.+Frech&amp;author=X.+Jiang&amp;volume=5&amp;publication_year=2014&amp;pages=5696&amp;pmid=25526346&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib5">5. <span class="element-citation" id="sref5">National Comprehensive Cancer Network  . 2022. NCCN Clinical Practice Guideline in Oncology. Hepatobiliary Cancers. Version 2.2022. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=National+Comprehensive+Cancer+Network+NCCN+Clinical+Practice+Guideline+in+Oncology.+Hepatobiliary+Cancers.+Version+2.2022+2022+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib6">6. <span class="element-citation" id="sref6">Kam A.E., Masood A., Shroff R.T. Current and emerging therapies for advanced biliary tract cancers. <span><span class="ref-journal">Lancet. Gastroenterol. Hepatol. </span>2021;<span class="ref-vol">6</span>:956–969.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34626563" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet.+Gastroenterol.+Hepatol.&amp;title=Current+and+emerging+therapies+for+advanced+biliary+tract+cancers&amp;author=A.E.+Kam&amp;author=A.+Masood&amp;author=R.T.+Shroff&amp;volume=6&amp;publication_year=2021&amp;pages=956-969&amp;pmid=34626563&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib7">7. <span class="element-citation" id="sref7">Sahasrabuddhe N.A., Barbhuiya M.A., Bhunia S., Subbannayya T., Gowda H., Advani J., Shrivastav B.R., Navani S., Leal P., Roa J.C., et al. Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics. <span><span class="ref-journal">Biochem. Biophys. Res. Commun. </span>2014;<span class="ref-vol">446</span>:863–869.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4696041/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24657443" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+Biophys.+Res.+Commun.&amp;title=Identification+of+prosaposin+and+transgelin+as+potential+biomarkers+for+gallbladder+cancer+using+quantitative+proteomics&amp;author=N.A.+Sahasrabuddhe&amp;author=M.A.+Barbhuiya&amp;author=S.+Bhunia&amp;author=T.+Subbannayya&amp;author=H.+Gowda&amp;volume=446&amp;publication_year=2014&amp;pages=863-869&amp;pmid=24657443&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib8">8. <span class="element-citation" id="sref8">Huang H.L., Yao H.S., Wang Y., Wang W.J., Hu Z.Q., Jin K.Z. Proteomic identification of tumor biomarkers associated with primary gallbladder cancer. <span><span class="ref-journal">World J. Gastroenterol. </span>2014;<span class="ref-vol">20</span>:5511–5518.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4017066/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24833881" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J.+Gastroenterol.&amp;title=Proteomic+identification+of+tumor+biomarkers+associated+with+primary+gallbladder+cancer&amp;author=H.L.+Huang&amp;author=H.S.+Yao&amp;author=Y.+Wang&amp;author=W.J.+Wang&amp;author=Z.Q.+Hu&amp;volume=20&amp;publication_year=2014&amp;pages=5511-5518&amp;pmid=24833881&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib9">9. <span class="element-citation" id="sref9">Sharma P., Bhunia S., Poojary S.S., Tekcham D.S., Barbhuiya M.A., Gupta S., Shrivastav B.R., Tiwari P.K. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease. <span><span class="ref-journal">Tumour Biol. </span>2016;<span class="ref-vol">37</span>:14687–14699.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27623942" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Tumour+Biol.&amp;title=Global+methylation+profiling+to+identify+epigenetic+signature+of+gallbladder+cancer+and+gallstone+disease&amp;author=P.+Sharma&amp;author=S.+Bhunia&amp;author=S.S.+Poojary&amp;author=D.S.+Tekcham&amp;author=M.A.+Barbhuiya&amp;volume=37&amp;publication_year=2016&amp;pages=14687-14699&amp;pmid=27623942&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib10">10. <span class="element-citation" id="sref10">Wang W., Ai K.X., Yuan Z., Huang X.Y., Zhang H.Z. Different expression of S100A8 in malignant and benign gallbladder diseases. <span><span class="ref-journal">Dig. Dis. Sci. </span>2013;<span class="ref-vol">58</span>:150–162.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22806545" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dig.+Dis.+Sci.&amp;title=Different+expression+of+S100A8+in+malignant+and+benign+gallbladder+diseases&amp;author=W.+Wang&amp;author=K.X.+Ai&amp;author=Z.+Yuan&amp;author=X.Y.+Huang&amp;author=H.Z.+Zhang&amp;volume=58&amp;publication_year=2013&amp;pages=150-162&amp;pmid=22806545&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib11">11. <span class="element-citation" id="sref11">Tuveson D., Clevers H. Cancer modeling meets human organoid technology. <span><span class="ref-journal">Science. </span>2019;<span class="ref-vol">364</span>:952–955.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31171691" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Cancer+modeling+meets+human+organoid+technology&amp;author=D.+Tuveson&amp;author=H.+Clevers&amp;volume=364&amp;publication_year=2019&amp;pages=952-955&amp;pmid=31171691&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib12">12. <span class="element-citation" id="sref12">Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in&#x000a0;vitro without a mesenchymal niche. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">459</span>:262–265.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19329995" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Single+Lgr5+stem+cells+build+crypt-villus+structures+in&#x000a0;vitro+without+a+mesenchymal+niche&amp;author=T.+Sato&amp;author=R.G.+Vries&amp;author=H.J.+Snippert&amp;author=M.+van+de+Wetering&amp;author=N.+Barker&amp;volume=459&amp;publication_year=2009&amp;pages=262-265&amp;pmid=19329995&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib13">13. <span class="element-citation" id="sref13">Driehuis E., Kretzschmar K., Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications. <span><span class="ref-journal">Nat. Protoc. </span>2020;<span class="ref-vol">15</span>:3380–3409.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32929210" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Protoc.&amp;title=Establishment+of+patient-derived+cancer+organoids+for+drug-screening+applications&amp;author=E.+Driehuis&amp;author=K.+Kretzschmar&amp;author=H.+Clevers&amp;volume=15&amp;publication_year=2020&amp;pages=3380-3409&amp;pmid=32929210&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib14">14. <span class="element-citation" id="sref14">Maru Y., Orihashi K., Hippo Y. Lentivirus-Based Stable Gene Delivery into Intestinal Organoids. <span><span class="ref-journal">Methods Mol. Biol. </span>2016;<span class="ref-vol">1422</span>:13–21.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27246018" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Mol.+Biol.&amp;title=Lentivirus-Based+Stable+Gene+Delivery+into+Intestinal+Organoids&amp;author=Y.+Maru&amp;author=K.+Orihashi&amp;author=Y.+Hippo&amp;volume=1422&amp;publication_year=2016&amp;pages=13-21&amp;pmid=27246018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib15">15. <span class="element-citation" id="sref15">Maru Y., Onuma K., Ochiai M., Imai T., Hippo Y. Shortcuts to intestinal carcinogenesis by genetic engineering in organoids. <span><span class="ref-journal">Cancer Sci. </span>2019;<span class="ref-vol">110</span>:858–866.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6398887/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30637899" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci.&amp;title=Shortcuts+to+intestinal+carcinogenesis+by+genetic+engineering+in+organoids&amp;author=Y.+Maru&amp;author=K.+Onuma&amp;author=M.+Ochiai&amp;author=T.+Imai&amp;author=Y.+Hippo&amp;volume=110&amp;publication_year=2019&amp;pages=858-866&amp;pmid=30637899&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib16">16. <span class="element-citation" id="sref16">Ochiai M., Yoshihara Y., Maru Y., Matsuura T., Izumiya M., Imai T., Hippo Y. Kras-driven heterotopic tumor development from hepatobiliary organoids. <span><span class="ref-journal">Carcinogenesis. </span>2019;<span class="ref-vol">40</span>:1142–1152.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30753336" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Kras-driven+heterotopic+tumor+development+from+hepatobiliary+organoids&amp;author=M.+Ochiai&amp;author=Y.+Yoshihara&amp;author=Y.+Maru&amp;author=T.+Matsuura&amp;author=M.+Izumiya&amp;volume=40&amp;publication_year=2019&amp;pages=1142-1152&amp;pmid=30753336&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib17">17. <span class="element-citation" id="sref17">Rupaimoole R., Slack F.J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. <span><span class="ref-journal">Nat. Rev. Drug Discov. </span>2017;<span class="ref-vol">16</span>:203–222.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28209991" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Drug+Discov.&amp;title=MicroRNA+therapeutics:+towards+a+new+era+for+the+management+of+cancer+and+other+diseases&amp;author=R.+Rupaimoole&amp;author=F.J.+Slack&amp;volume=16&amp;publication_year=2017&amp;pages=203-222&amp;pmid=28209991&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib18">18. <span class="element-citation" id="sref18">Kitamura T., Connolly K., Ruffino L., Ajiki T., Lueckgen A., DiGiovanni J., Kiguchi K. The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice. <span><span class="ref-journal">J.&#x000a0;Hepatol. </span>2012;<span class="ref-vol">57</span>:84–91.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3378818/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22326466" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Hepatol.&amp;title=The+therapeutic+effect+of+histone+deacetylase+inhibitor+PCI-24781+on+gallbladder+carcinoma+in+BK5.erbB2+mice&amp;author=T.+Kitamura&amp;author=K.+Connolly&amp;author=L.+Ruffino&amp;author=T.+Ajiki&amp;author=A.+Lueckgen&amp;volume=57&amp;publication_year=2012&amp;pages=84-91&amp;pmid=22326466&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib19">19. <span class="element-citation" id="sref19">Jin K., Xiang Y., Tang J., Wu G., Li J., Xiao H., Li C., Chen Y., Zhao J. miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells. <span><span class="ref-journal">Tumour Biol. </span>2014;<span class="ref-vol">35</span>:1503–1510.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24078448" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Tumour+Biol.&amp;title=miR-34+is+associated+with+poor+prognosis+of+patients+with+gallbladder+cancer+through+regulating+telomere+length+in+tumor+stem+cells&amp;author=K.+Jin&amp;author=Y.+Xiang&amp;author=J.+Tang&amp;author=G.+Wu&amp;author=J.+Li&amp;volume=35&amp;publication_year=2014&amp;pages=1503-1510&amp;pmid=24078448&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib20">20. <span class="element-citation" id="sref20">Zhou H., Guo W., Zhao Y., Wang Y., Zha R., Ding J., Liang L., Yang G., Chen Z., Ma B., Yin B. MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer. <span><span class="ref-journal">Cancer Sci. </span>2014;<span class="ref-vol">105</span>:956–965.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4317855/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24903309" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci.&amp;title=MicroRNA-135a+acts+as+a+putative+tumor+suppressor+by+directly+targeting+very+low+density+lipoprotein+receptor+in+human+gallbladder+cancer&amp;author=H.+Zhou&amp;author=W.+Guo&amp;author=Y.+Zhao&amp;author=Y.+Wang&amp;author=R.+Zha&amp;volume=105&amp;publication_year=2014&amp;pages=956-965&amp;pmid=24903309&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib21">21. <span class="element-citation" id="sref21">Indrieri A., Carrella S., Carotenuto P., Banfi S., Franco B. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2020;<span class="ref-vol">21</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7139714/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32197476" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=The+Pervasive+Role+of+the+miR-181+Family+in+Development,+Neurodegeneration,+and+Cancer&amp;author=A.+Indrieri&amp;author=S.+Carrella&amp;author=P.+Carotenuto&amp;author=S.+Banfi&amp;author=B.+Franco&amp;volume=21&amp;publication_year=2020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib22">22. <span class="element-citation" id="sref22">Zhang G.J., Zhou H., Xiao H.X., Li Y., Zhou T. MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. <span><span class="ref-journal">BMC Cancer. </span>2014;<span class="ref-vol">14</span>:109.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3974114/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24555885" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;title=MiR-378+is+an+independent+prognostic+factor+and+inhibits+cell+growth+and+invasion+in+colorectal+cancer&amp;author=G.J.+Zhang&amp;author=H.+Zhou&amp;author=H.X.+Xiao&amp;author=Y.+Li&amp;author=T.+Zhou&amp;volume=14&amp;publication_year=2014&amp;pages=109&amp;pmid=24555885&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib23">23. <span class="element-citation" id="sref23">Ferrari E., Gandellini P. Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms. <span><span class="ref-journal">Cell Death Dis. </span>2020;<span class="ref-vol">11</span>:980.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7667162/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33191398" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis.&amp;title=Unveiling+the+ups+and+downs+of+miR-205+in+physiology+and+cancer:+transcriptional+and+post-transcriptional+mechanisms&amp;author=E.+Ferrari&amp;author=P.+Gandellini&amp;volume=11&amp;publication_year=2020&amp;pages=980&amp;pmid=33191398&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib24">24. <span class="element-citation" id="sref24">Hermeking H. The miR-34 family in cancer and apoptosis. <span><span class="ref-journal">Cell Death Differ. </span>2010;<span class="ref-vol">17</span>:193–199.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19461653" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Differ.&amp;title=The+miR-34+family+in+cancer+and+apoptosis&amp;author=H.+Hermeking&amp;volume=17&amp;publication_year=2010&amp;pages=193-199&amp;pmid=19461653&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib25">25. <span class="element-citation" id="sref25">Zhang L., Liao Y., Tang L. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. <span><span class="ref-journal">J.&#x000a0;Exp. Clin. Cancer Res. </span>2019;<span class="ref-vol">38</span>:53.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6360685/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30717802" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Exp.+Clin.+Cancer+Res.&amp;title=MicroRNA-34+family:+a+potential+tumor+suppressor+and+therapeutic+candidate+in+cancer&amp;author=L.+Zhang&amp;author=Y.+Liao&amp;author=L.+Tang&amp;volume=38&amp;publication_year=2019&amp;pages=53&amp;pmid=30717802&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib26">26. <span class="element-citation" id="sref26">Goeppert B., Truckenmueller F., Ori A., Fritz V., Albrecht T., Fraas A., Scherer D., Silos R.G., Sticht C., Gretz N., et al. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p. <span><span class="ref-journal">Sci. Rep. </span>2019;<span class="ref-vol">9</span>:4796.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6423323/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30886199" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=Profiling+of+gallbladder+carcinoma+reveals+distinct+miRNA+profiles+and+activation+of+STAT1+by+the+tumor+suppressive+miRNA-145-5p&amp;author=B.+Goeppert&amp;author=F.+Truckenmueller&amp;author=A.+Ori&amp;author=V.+Fritz&amp;author=T.+Albrecht&amp;volume=9&amp;publication_year=2019&amp;pages=4796&amp;pmid=30886199&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib27">27. <span class="element-citation" id="sref27">Sun F., Fu H., Liu Q., Tie Y., Zhu J., Xing R., Sun Z., Zheng X. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. <span><span class="ref-journal">FEBS Lett. </span>2008;<span class="ref-vol">582</span>:1564–1568.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18406353" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett.&amp;title=Downregulation+of+CCND1+and+CDK6+by+miR-34a+induces+cell+cycle+arrest&amp;author=F.+Sun&amp;author=H.+Fu&amp;author=Q.+Liu&amp;author=Y.+Tie&amp;author=J.+Zhu&amp;volume=582&amp;publication_year=2008&amp;pages=1564-1568&amp;pmid=18406353&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib28">28. <span class="element-citation" id="sref28">Cao W., Yang W., Fan R., Li H., Jiang J., Geng M., Jin Y., Wu Y. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway. <span><span class="ref-journal">Tumour Biol. </span>2014;<span class="ref-vol">35</span>:1287–1295.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24068565" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Tumour+Biol.&amp;title=miR-34a+regulates+cisplatin-induce+gastric+cancer+cell+death+by+modulating+PI3K/AKT/survivin+pathway&amp;author=W.+Cao&amp;author=W.+Yang&amp;author=R.+Fan&amp;author=H.+Li&amp;author=J.+Jiang&amp;volume=35&amp;publication_year=2014&amp;pages=1287-1295&amp;pmid=24068565&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib29">29. <span class="element-citation" id="sref29">He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., et al. A microRNA component of the p53 tumour suppressor network. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">447</span>:1130–1134.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4590999/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17554337" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+microRNA+component+of+the+p53+tumour+suppressor+network&amp;author=L.+He&amp;author=X.+He&amp;author=L.P.+Lim&amp;author=E.+de+Stanchina&amp;author=Z.+Xuan&amp;volume=447&amp;publication_year=2007&amp;pages=1130-1134&amp;pmid=17554337&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib30">30. <span class="element-citation" id="sref30">Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. <span><span class="ref-journal">Cancer Res. </span>2007;<span class="ref-vol">67</span>:8433–8438.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17823410" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=MicroRNA-34b+and+MicroRNA-34c+are+targets+of+p53+and+cooperate+in+control+of+cell+proliferation+and+adhesion-independent+growth&amp;author=D.C.+Corney&amp;author=A.+Flesken-Nikitin&amp;author=A.K.+Godwin&amp;author=W.+Wang&amp;author=A.Y.+Nikitin&amp;volume=67&amp;publication_year=2007&amp;pages=8433-8438&amp;pmid=17823410&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib31">31. <span class="element-citation" id="sref31">Vogt M., Munding J., Gr&#x000fc;ner M., Liffers S.T., Verdoodt B., Hauk J., Steinstraesser L., Tannapfel A., Hermeking H. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. <span><span class="ref-journal">Virchows Arch. </span>2011;<span class="ref-vol">458</span>:313–322.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21225432" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virchows+Arch.&amp;title=Frequent+concomitant+inactivation+of+miR-34a+and+miR-34b/c+by+CpG+methylation+in+colorectal,+pancreatic,+mammary,+ovarian,+urothelial,+and+renal+cell+carcinomas+and+soft+tissue+sarcomas&amp;author=M.+Vogt&amp;author=J.+Munding&amp;author=M.+Gr&#x000fc;ner&amp;author=S.T.+Liffers&amp;author=B.+Verdoodt&amp;volume=458&amp;publication_year=2011&amp;pages=313-322&amp;pmid=21225432&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib32">32. <span class="element-citation" id="sref32">Thomson D.W., Dinger M.E. Endogenous microRNA sponges: evidence and controversy. <span><span class="ref-journal">Nat. Rev. Genet. </span>2016;<span class="ref-vol">17</span>:272–283.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27040487" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Genet.&amp;title=Endogenous+microRNA+sponges:+evidence+and+controversy&amp;author=D.W.+Thomson&amp;author=M.E.+Dinger&amp;volume=17&amp;publication_year=2016&amp;pages=272-283&amp;pmid=27040487&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib33">33. <span class="element-citation" id="sref33">Li S., Zhu K., Liu L., Gu J., Niu H., Guo J. lncARSR sponges miR-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis. <span><span class="ref-journal">Cancer Sci. </span>2020;<span class="ref-vol">111</span>:3938–3952.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7540992/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32798250" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci.&amp;title=lncARSR+sponges+miR-34a-5p+to+promote+colorectal+cancer+invasion+and+metastasis+via+hexokinase-1-mediated+glycolysis&amp;author=S.+Li&amp;author=K.+Zhu&amp;author=L.+Liu&amp;author=J.+Gu&amp;author=H.+Niu&amp;volume=111&amp;publication_year=2020&amp;pages=3938-3952&amp;pmid=32798250&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib34">34. <span class="element-citation" id="sref34">Giraldo N.A., Drill E., Satravada B.A., Dika I.E., Brannon A.R., Dermawan J., Mohanty A., Ozcan K., Chakravarty D., Benayed R., et al. Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention. <span><span class="ref-journal">Clin. Cancer Res. </span>2022;<span class="ref-vol">28</span>:5359–5367.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9772093/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36228155" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Cancer+Res.&amp;title=Comprehensive+Molecular+Characterization+of+Gallbladder+Carcinoma+and+Potential+Targets+for+Intervention&amp;author=N.A.+Giraldo&amp;author=E.+Drill&amp;author=B.A.+Satravada&amp;author=I.E.+Dika&amp;author=A.R.+Brannon&amp;volume=28&amp;publication_year=2022&amp;pages=5359-5367&amp;pmid=36228155&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib35">35. <span class="element-citation" id="sref35">Li Y., Guessous F., Zhang Y., Dipierro C., Kefas B., Johnson E., Marcinkiewicz L., Jiang J., Yang Y., Schmittgen T.D., et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. <span><span class="ref-journal">Cancer Res. </span>2009;<span class="ref-vol">69</span>:7569–7576.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2756313/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19773441" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=MicroRNA-34a+inhibits+glioblastoma+growth+by+targeting+multiple+oncogenes&amp;author=Y.+Li&amp;author=F.+Guessous&amp;author=Y.+Zhang&amp;author=C.+Dipierro&amp;author=B.+Kefas&amp;volume=69&amp;publication_year=2009&amp;pages=7569-7576&amp;pmid=19773441&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib36">36. <span class="element-citation" id="sref36">Ji Q., Hao X., Meng Y., Zhang M., Desano J., Fan D., Xu L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. <span><span class="ref-journal">BMC Cancer. </span>2008;<span class="ref-vol">8</span>:266.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2564978/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18803879" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;title=Restoration+of+tumor+suppressor+miR-34+inhibits+human+p53-mutant+gastric+cancer+tumorspheres&amp;author=Q.+Ji&amp;author=X.+Hao&amp;author=Y.+Meng&amp;author=M.+Zhang&amp;author=J.+Desano&amp;volume=8&amp;publication_year=2008&amp;pages=266&amp;pmid=18803879&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib37">37. <span class="element-citation" id="sref37">Nalls D., Tang S.N., Rodova M., Srivastava R.K., Shankar S. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. <span><span class="ref-journal">PLoS One. </span>2011;<span class="ref-vol">6</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3166078/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21909380" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Targeting+epigenetic+regulation+of+miR-34a+for+treatment+of+pancreatic+cancer+by+inhibition+of+pancreatic+cancer+stem+cells&amp;author=D.+Nalls&amp;author=S.N.+Tang&amp;author=M.+Rodova&amp;author=R.K.+Srivastava&amp;author=S.+Shankar&amp;volume=6&amp;publication_year=2011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib38">38. <span class="element-citation" id="sref38">Martini S., Zuco V., Tortoreto M., Percio S., Campi E., El Bezawy R., Doldi V., Landesman Y., Pennati M., Zaffaroni N. miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer. <span><span class="ref-journal">Pharmaceuticals. </span>2021;<span class="ref-vol">14</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8227962/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34072442" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=miR-34a-Mediated+Survivin+Inhibition+Improves+the+Antitumor+Activity+of+Selinexor+in+Triple-Negative+Breast+Cancer&amp;author=S.+Martini&amp;author=V.+Zuco&amp;author=M.+Tortoreto&amp;author=S.+Percio&amp;author=E.+Campi&amp;volume=14&amp;publication_year=2021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib39">39. <span class="element-citation" id="sref39">Peng Y., Fan J.Y., Xiong J., Lou Y., Zhu Y. miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin. <span><span class="ref-journal">Pathobiology. </span>2019;<span class="ref-vol">86</span>:296–305.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31711057" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pathobiology&amp;title=miR-34a+Enhances+the+Susceptibility+of+Gastric+Cancer+to+Platycodin+D+by+Targeting+Survivin&amp;author=Y.+Peng&amp;author=J.Y.+Fan&amp;author=J.+Xiong&amp;author=Y.+Lou&amp;author=Y.+Zhu&amp;volume=86&amp;publication_year=2019&amp;pages=296-305&amp;pmid=31711057&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib40">40. <span class="element-citation" id="sref40">Tang Y., Tang Y., Cheng Y.S. miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway. <span><span class="ref-journal">Sci. Rep. </span>2017;<span class="ref-vol">7</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5286431/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28145431" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=miR-34a+inhibits+pancreatic+cancer+progression+through+Snail1-mediated+epithelial-mesenchymal+transition+and+the+Notch+signaling+pathway&amp;author=Y.+Tang&amp;author=Y.+Tang&amp;author=Y.S.+Cheng&amp;volume=7&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib41">41. <span class="element-citation" id="sref41">Lin Y., Li X.Y., Willis A.L., Liu C., Chen G., Weiss S.J. Snail1-dependent control of embryonic stem cell pluripotency and lineage commitment. <span><span class="ref-journal">Nat. Commun. </span>2014;<span class="ref-vol">5</span>:3070.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4115678/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24401905" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Commun.&amp;title=Snail1-dependent+control+of+embryonic+stem+cell+pluripotency+and+lineage+commitment&amp;author=Y.+Lin&amp;author=X.Y.+Li&amp;author=A.L.+Willis&amp;author=C.+Liu&amp;author=G.+Chen&amp;volume=5&amp;publication_year=2014&amp;pages=3070&amp;pmid=24401905&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib42">42. <span class="element-citation" id="sref42">Grande M.T., S&#x000e1;nchez-Laorden B., L&#x000f3;pez-Blau C., De Frutos C.A., Boutet A., Ar&#x000e9;valo M., Rowe R.G., Weiss S.J., L&#x000f3;pez-Novoa J.M., Nieto M.A. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. <span><span class="ref-journal">Nat. Med. </span>2015;<span class="ref-vol">21</span>:989–997.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26236989" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Med.&amp;title=Snail1-induced+partial+epithelial-to-mesenchymal+transition+drives+renal+fibrosis+in+mice+and+can+be+targeted+to+reverse+established+disease&amp;author=M.T.+Grande&amp;author=B.+S&#x000e1;nchez-Laorden&amp;author=C.+L&#x000f3;pez-Blau&amp;author=C.A.+De+Frutos&amp;author=A.+Boutet&amp;volume=21&amp;publication_year=2015&amp;pages=989-997&amp;pmid=26236989&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib43">43. <span class="element-citation" id="sref43">Zhang X., Ai F., Li X., Tian L., Wang X., Shen S., Liu F. MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling. <span><span class="ref-journal">Oncol. Lett. </span>2017;<span class="ref-vol">14</span>:2325–2333.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5530141/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28781671" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.+Lett.&amp;title=MicroRNA-34a+suppresses+colorectal+cancer+metastasis+by+regulating+Notch+signaling&amp;author=X.+Zhang&amp;author=F.+Ai&amp;author=X.+Li&amp;author=L.+Tian&amp;author=X.+Wang&amp;volume=14&amp;publication_year=2017&amp;pages=2325-2333&amp;pmid=28781671&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib44">44. <span class="element-citation" id="sref44">Hong D.S., Kang Y.K., Borad M., Sachdev J., Ejadi S., Lim H.Y., Brenner A.J., Park K., Lee J.L., Kim T.Y., et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. <span><span class="ref-journal">Br. J. Cancer. </span>2020;<span class="ref-vol">122</span>:1630–1637.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7251107/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32238921" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br.+J.+Cancer&amp;title=Phase+1+study+of+MRX34,+a+liposomal+miR-34a+mimic,+in+patients+with+advanced+solid+tumours&amp;author=D.S.+Hong&amp;author=Y.K.+Kang&amp;author=M.+Borad&amp;author=J.+Sachdev&amp;author=S.+Ejadi&amp;volume=122&amp;publication_year=2020&amp;pages=1630-1637&amp;pmid=32238921&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib45">45. <span class="element-citation" id="sref45">Li W.J., Wang Y., Liu R., Kasinski A.L., Shen H., Slack F.J., Tang D.G. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. <span><span class="ref-journal">Front. Cell Dev. Biol. </span>2021;<span class="ref-vol">9</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7982597/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33763422" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Cell+Dev.+Biol.&amp;title=MicroRNA-34a:+Potent+Tumor+Suppressor,+Cancer+Stem+Cell+Inhibitor,+and+Potential+Anticancer+Therapeutic&amp;author=W.J.+Li&amp;author=Y.+Wang&amp;author=R.+Liu&amp;author=A.L.+Kasinski&amp;author=H.+Shen&amp;volume=9&amp;publication_year=2021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib46">46. <span class="element-citation" id="sref46">Larghi A., Rimba&#x00219; M., Rizzatti G., Carbone C., Gasbarrini A., Costamagna G., Alfieri S., Tortora G. Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview. <span><span class="ref-journal">Semin. Oncol. </span>2021;<span class="ref-vol">48</span>:95–105.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33608132" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin.+Oncol.&amp;title=Endoscopic+ultrasound-guided+therapies+for+pancreatic+solid+tumors:+An+overview&amp;author=A.+Larghi&amp;author=M.+Rimba&#x00219;&amp;author=G.+Rizzatti&amp;author=C.+Carbone&amp;author=A.+Gasbarrini&amp;volume=48&amp;publication_year=2021&amp;pages=95-105&amp;pmid=33608132&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib47">47. <span class="element-citation" id="sref47">Ueta E., Tsutsumi K., Kato H., Matsushita H., Shiraha H., Fujii M., Matsumoto K., Horiguchi S., Okada H. Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients. <span><span class="ref-journal">Sci. Rep. </span>2021;<span class="ref-vol">11</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8192895/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34112884" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=Extracellular+vesicle-shuttled+miRNAs+as+a+diagnostic+and+prognostic+biomarker+and+their+potential+roles+in+gallbladder+cancer+patients&amp;author=E.+Ueta&amp;author=K.+Tsutsumi&amp;author=H.+Kato&amp;author=H.+Matsushita&amp;author=H.+Shiraha&amp;volume=11&amp;publication_year=2021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib48">48. <span class="element-citation" id="sref48">Homma S., Hasumura S., Nagamori S., Kameda H. [Establishment and characterization of a human gall bladder carcinoma cell line NOZ] <span><span class="ref-journal">Hum. Cell. </span>1988;<span class="ref-vol">1</span>:95–97.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3154020" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum.+Cell&amp;title=[Establishment+and+characterization+of+a+human+gall+bladder+carcinoma+cell+line+NOZ]&amp;author=S.+Homma&amp;author=S.+Hasumura&amp;author=S.+Nagamori&amp;author=H.+Kameda&amp;volume=1&amp;publication_year=1988&amp;pages=95-97&amp;pmid=3154020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib49">49. <span class="element-citation" id="sref49">Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. <span><span class="ref-journal">Methods. </span>2001;<span class="ref-vol">25</span>:402–408.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11846609" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods&amp;title=Analysis+of+relative+gene+expression+data+using+real-time+quantitative+PCR+and+the+2(-Delta+Delta+C(T))+Method&amp;author=K.J.+Livak&amp;author=T.D.+Schmittgen&amp;volume=25&amp;publication_year=2001&amp;pages=402-408&amp;pmid=11846609&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib50">50. <span class="element-citation" id="sref50">Bankhead P., Loughrey M.B., Fern&#x000e1;ndez J.A., Dombrowski Y., McArt D.G., Dunne P.D., McQuaid S., Gray R.T., Murray L.J., Coleman H.G., et al. QuPath: Open source software for digital pathology image analysis. <span><span class="ref-journal">Sci. Rep. </span>2017;<span class="ref-vol">7</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5715110/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29203879" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=QuPath:+Open+source+software+for+digital+pathology+image+analysis&amp;author=P.+Bankhead&amp;author=M.B.+Loughrey&amp;author=J.A.+Fern&#x000e1;ndez&amp;author=Y.+Dombrowski&amp;author=D.G.+McArt&amp;volume=7&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib51">51. <span class="element-citation" id="sref51">Huang H.Y., Lin Y.C.D., Cui S., Huang Y., Tang Y., Xu J., Bao J., Li Y., Wen J., Zuo H., et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. <span><span class="ref-journal">Nucleic Acids Res. </span>2022;<span class="ref-vol">50</span>:D222–D230.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8728135/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34850920" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res.&amp;title=miRTarBase+update+2022:+an+informative+resource+for+experimentally+validated+miRNA-target+interactions&amp;author=H.Y.+Huang&amp;author=Y.C.D.+Lin&amp;author=S.+Cui&amp;author=Y.+Huang&amp;author=Y.+Tang&amp;volume=50&amp;publication_year=2022&amp;pages=D222-D230&amp;pmid=34850920&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib52">52. <span class="element-citation" id="sref52">Ge S.X., Jung D., Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. <span><span class="ref-journal">Bioinformatics. </span>2020;<span class="ref-vol">36</span>:2628–2629.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7178415/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31882993" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=ShinyGO:+a+graphical+gene-set+enrichment+tool+for+animals+and+plants&amp;author=S.X.+Ge&amp;author=D.+Jung&amp;author=R.+Yao&amp;volume=36&amp;publication_year=2020&amp;pages=2628-2629&amp;pmid=31882993&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib53">53. <span class="element-citation" id="sref53">Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>2005;<span class="ref-vol">102</span>:15545–15550.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1239896/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16199517" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Gene+set+enrichment+analysis:+a+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles&amp;author=A.+Subramanian&amp;author=P.+Tamayo&amp;author=V.K.+Mootha&amp;author=S.+Mukherjee&amp;author=B.L.+Ebert&amp;volume=102&amp;publication_year=2005&amp;pages=15545-15550&amp;pmid=16199517&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib54">54. <span class="element-citation" id="sref54">Chen Y., Wang X. miRDB: an online database for prediction of functional microRNA targets. <span><span class="ref-journal">Nucleic Acids Res. </span>2020;<span class="ref-vol">48</span>:D127–D131.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6943051/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31504780" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res.&amp;title=miRDB:+an+online+database+for+prediction+of+functional+microRNA+targets&amp;author=Y.+Chen&amp;author=X.+Wang&amp;volume=48&amp;publication_year=2020&amp;pages=D127-D131&amp;pmid=31504780&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib55">55. <span class="element-citation" id="sref55">Takei Y., Takigahira M., Mihara K., Tarumi Y., Yanagihara K. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. <span><span class="ref-journal">Cancer Res. </span>2011;<span class="ref-vol">71</span>:1442–1453.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21169410" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=The+metastasis-associated+microRNA+miR-516a-3p+is+a+novel+therapeutic+target+for+inhibiting+peritoneal+dissemination+of+human+scirrhous+gastric+cancer&amp;author=Y.+Takei&amp;author=M.+Takigahira&amp;author=K.+Mihara&amp;author=Y.+Tarumi&amp;author=K.+Yanagihara&amp;volume=71&amp;publication_year=2011&amp;pages=1442-1453&amp;pmid=21169410&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib56">56. <span class="element-citation" id="sref56">Kojima Y., Nishina T., Nakano H., Okumura K., Takeda K. Inhibition of Importin beta1 Augments the Anticancer Effect of Agonistic Anti-Death Receptor 5 Antibody in TRAIL-resistant Tumor Cells. <span><span class="ref-journal">Mol. Cancer Therapeut. </span>2020;<span class="ref-vol">19</span>:1123–1133.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32156787" ref="reftype=pubmed&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cancer+Therapeut.&amp;title=Inhibition+of+Importin+beta1+Augments+the+Anticancer+Effect+of+Agonistic+Anti-Death+Receptor+5+Antibody+in+TRAIL-resistant+Tumor+Cells&amp;author=Y.+Kojima&amp;author=T.+Nishina&amp;author=H.+Nakano&amp;author=K.+Okumura&amp;author=K.+Takeda&amp;volume=19&amp;publication_year=2020&amp;pages=1123-1133&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10963938&amp;issue-id=455933&amp;journal-id=4545&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Molecular Therapy Oncology</span> are provided here courtesy of <strong>American Society of Gene &#x0026; Cell Therapy</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10963938/pdf/main.pdf" class="int-view">PDF (3.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10963938/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10963938/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10963938" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10963938%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="g0SpYhFiyGmk5LZtRsTdZtDF3DRp2mK4jzikbaR7k9NwBpp4DyQKk8WEu3XXdM1G">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10963938%2F&amp;text=MicroRNA-34a-5p%3A%20A%20pivotal%20therapeutic%20target%20in%20gallbladder%20cancer" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10963938%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10963938/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10963938/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38596294/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10963938/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38596294/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10963938/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10963938/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10963938/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
